Delivery Order SPE2DB22D1041-SPE2DB25FUBB1
- Not listed
- The Defense Logistics Agency awarded a $4,211.79 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Imitrex 6 mg/0.5 mL pen injectors. This firm fixed price, non-set-aside contract is scheduled for completion by August 1, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of the company's extensive pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Imitrex 6 mg/0.5 mL pen injectors with a firm fixed price ceiling value of $1,501.15 and completion date of July 31, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through...
- The Defense Logistics Agency awarded a delivery order valued at $1,712.54 to AmerisourceBergen Drug Corp for Imitrex 6 mg/0.5 ml pen injections on August 7, 2025, with an ultimate completion date of August 8, 2025. This competitive award carries firm fixed pricing and involves no set-aside designation. The pharmaceutical product will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,995.78 on May 20, 2025, for the supply of Imitrex 6 mg/0.5 mL pen injectors in 0.5 mL quantities. This is a firm fixed price, non-set-aside competitive award with an ultimate completion date of May 21, 2025, and performance location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's pharmaceutical supply relationship with DLA, one of the Department of...
- The Defense Logistics Agency awarded a $5,405.03 delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Imitrex 4 mg/0.5 mL pen injections (0.5 mL units). The contract represents a firm fixed price delivery order with an ultimate completion date of April 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a $5,869.17 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Imitrex 6 mg/0.5 mL pen injectors with an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Imitrex (sumatriptan) is a prescription medication used to treat migraine headaches, and this...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Imitrex 6 mg/0.5 mL pen injectors in 0.5 mL unit doses, with a ceiling value of $1,599.58. This is a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, and represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Imitrex 6 mg/0.5 ml pen injectors with a ceiling value of $1,434.02 and an ultimate completion date of June 2, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreements with the federal government. The product will be delivered to the vendor's...
- AmerisourceBergen Drug Corp was awarded a $4,896.10 delivery order by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025, for the supply of Imitrex 6 mg/0.5 mL pen injectors. This firm fixed-price contract, designated as a non-set-aside award, is scheduled for completion by July 29, 2025, with performance to be executed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- On July 29, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a $2,905.89 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Imitrex 6 mg/0.5 mL pen injectors. This is a non-set-aside contract awarded through open competition, with an ultimate completion date of July 30, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA 19428....
- SPE2DB22D1041Indefinite Delivery Contract
- SPE2DB22D1041-SPE2DB25FUBB1Delivery Order
The Defense Logistics Agency awarded a $13,635.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of Imitrex 6 mg/0.5 ml pen injectors. The contract, which carries an ultimate completion date of July 14, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen will perform this work from its corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), an approximately $1 billion vehicle valued through December 2026 that serves as a comprehensive global pharmaceutical support platform for military healthcare programs. AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor for federal medical procurement, particularly supporting the Defense Health Agency and other military healthcare systems. The company's contract portfolio demonstrates extensive experience fulfilling federal requirements for brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This specific delivery order for sumatriptan auto-injectors aligns with the company's established role as a prime vendor supplying neurological treatments and other specialized pharmaceuticals to support military readiness and veteran healthcare operations. The competitive award underscores AmerisourceBergen's capability to meet stringent federal procurement standards through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.6k | 7/11/25 |